HCW Biologics Files Prospectus For Resale Of Up To 1,807,228 Shares Underlying Armistice Capital Warrants

Benzinga Newsdesk www.benzinga.com Neutral 93.3%

Neg 0% Neu 93.3% Pos 0%

https://www.sec.gov/Archives/edgar/data/1828673/000149315226045532/forms-1.htm

Comments

No comments yet. Be the first!